| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697226 | Brachytherapy | 2016 | 6 Pages |
Abstract
Among a cohort of brachytherapy patients, we identified no significant difference in survival for delayed salvage hormonal therapy. Shorter PSA doubling time and time to BCR are significantly associated with adverse outcomes, and these patients should be considered for immediate salvage therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Daniel Sagalovich, Michael Leapman, John Sfakianos, Simon Hall, Richard Stock, Nelson Stone,